Heartflow (NASDAQ:HTFL) Now Covered by Analysts at Piper Sandler

Key Points

• Piper Sandler has initiated coverage of Heartflow (NASDAQ:HTFL), assigning an "overweight" rating with a price target of $38.00, suggesting a potential upside of 20.63% from the previous close.
• Other analysts, including Canaccord Genuity Group, also rated Heartflow with a "buy," setting a price objective of $35.00, indicating a consensus rating of "Buy" with an average price target of $36.33.
• Heartflow’s stock price has ranged from a one-year low of $26.56 to a high of $36.68, opening at $31.50 on the day of the report.

Piper Sandler assumed coverage on shares of Heartflow (NASDAQ:HTFL - Free Report) in a report issued on Tuesday, MarketBeat.com reports. The brokerage issued an overweight rating and a $38.00 price target on the stock.

Other equities research analysts have also issued reports about the company. Canaccord Genuity Group initiated coverage on Heartflow in a research note on Tuesday. They issued a "buy" rating and a $35.00 price objective for the company. Wall Street Zen raised Heartflow to a "hold" rating in a research note on Saturday, August 16th. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $35.80.

Heartflow Price Performance

Heartflow stock traded down $3.01 during midday trading on Tuesday, reaching $31.07. 442,043 shares of the stock traded hands, compared to its average volume of 878,154. Heartflow has a 12 month low of $26.56 and a 12 month high of $36.68.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.